Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. (GLUE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GLUE · as of Jun 8, 2026
Key Statistics
Explore Monte Rosa Therapeutics, Inc. Data
glue stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The GLUE analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $31.75, representing +88.97% upside from the current price of $16.80.
Competitors & Peers
glue competitorsGLUE
ARVN
AVBP
DAWN
DNA
GERNStock Performance
Full HistoryAbout Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade ther…
what is monte rosa therapeutics, inc. · glue stock overview · monte rosa therapeutics, inc. company profile · who is monte rosa therapeutics, inc. ceo · glue NASDAQ · monte rosa therapeutics, inc. headquarters · monte rosa therapeutics, inc. business segments
About Stock Overview & Key Data
Monte Rosa Therapeutics, Inc. (GLUE) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 24, 2021. As of the latest trading session, GLUE stock price is $16.80, with a market capitalization of $1.1B. The stock has returned +242.13% over the past 12 months and +7.35% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Monte Rosa Therapeutics, Inc. stock is Buy, with an average 12-month price target of $31.75. In fiscal year 2025, Monte Rosa Therapeutics, Inc. reported revenue of $123.7M and net income of -$38.6M. For detailed data — including Monte Rosa Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Monte Rosa Therapeutics, Inc. (GLUE) stock price is $16.80. The stock is traded on NASDAQ under the ticker symbol GLUE. The 52-week range is $4.12 – $25.77.